Earnings Summary – Cohance Lifesciences Reports Q3 and Nine-Month Revenue and Profit Decline Amid Inventory Normalization
● Feb 12, 2026
Cohance Lifesciences Limited (NSE: COHANCE) is a global contract research, development, and manufacturing organization focused on innovator partnerships. The company...